rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GRFS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Grifols (BME:GRF) Stock Price Trails Q3 Results As Debt Questions Linger
      Nov 3Yahoo FinanceGRFS
      Grifols: Plasma, Profits, And Recovery Gathering Momentum (NASDAQ:GRFS)
      Nov 3Seeking AlphaGRFS
      Grifols Beats Q3 Revenue Forecasts as Immunoglobulin Demand Supports Profit Growth
      Nov 3Yahoo FinanceGRFS
      Grifols SA (GRFS) Q3 2026 Earnings Call Highlights: Biopharma Growth Accelerates as Margin ...
      Nov 3Yahoo FinanceGRFS
      Grifols (GRFS) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 3The Globe and MailGRFS
      Grifols ADR earnings beat by $0.02, revenue topped estimates
      Nov 3Investing.comGRFS
      Grifols Q3 Earnings Call Highlights
      Nov 2Yahoo FinanceGRFS
      Grifols Q3 2026 slides: margin expansion drives leverage below 4x
      Nov 2Investing.comGRFS
      Earnings call transcript: Grifols rises on q3 2026 cash flow and margin gains
      Nov 2Investing.comGRFS
      Grifols stock up: Q3 revenue tops estimates as immunoglobulin sales drive growth
      Nov 2Yahoo FinanceGRFS
      Grifols Q3 Profit, Revenue Rise
      Nov 2Yahoo FinanceGRFS
      Grifols (BME:GRF) Stock Still Looks Cheap Based On Current Earnings
      Oct 27Yahoo FinanceGRFS
      Plasma Demand Supports Grifols, S.A.’s (GRFS) Path Back to Financial Strength
      Oct 23Yahoo FinanceGRFS
      Are Options Traders Betting on a Big Move in Grifols Stock?
      Oct 7Yahoo FinanceGRFS
      Grifols (BME:GRF) Stock May Be Below Fair Value On Earnings

      Grifols has seen a long share price slide in recent years, which naturally puts the focus on one question for investors who still follow the stock. Is the current price tag properly supported by the earnings the business is generating today. Over the past 5 years the share price has fallen 54%, which makes the current valuation story hinge on whether the market has already absorbed weaker sentiment into the earnings multiple. The group’s ability to turn its plasma based operations into...

      Sep 26Yahoo FinanceGRFS
      Grifols says Canada plasma license suspension has no impact on ongoing operations
      Sep 24ReutersGRFS
      Grifols Stock: Better Plasma Economics Can Unlock A Discounted Equity (NASDAQ:GRFS)
      Sep 17Seeking AlphaGRFS

      This is the newest page. Registered accounts read further back.